BGMS (Bio Green Med Solution) 3-Year EBITDA Growth Rate: 92.50% (As of Jun. 2026) — 46% Above Median

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

BGMS Bio Green Med Solution Inc BGMS
46 GF Score
Price $0.88
GF Value $2.61
Valuation Possible Value Trap
! 3 Warning Signs
View Full Analysis

What is Bio Green Med Solution 3-Year EBITDA Growth Rate?

Bio Green Med Solution BGMS +0.76% 46 3-Year EBITDA Growth Rate is 92.50% as of Jun. 2026, which is 46% above its 10-year median of 63.50. GuruFocus rates BGMS with a GF Score™ of 46/100 and a GF Value™ of $2.61 (Possible Value Trap). The stock has 3 warning signs investors should review. Among 1,450 Construction companies, Bio Green Med Solution ranks better than 95.31% on this metric.

Bio Green Med Solution's EBITDA per Share for the three months ended in Jun. 2026 was $-0.08.

During the past 3 years, the average EBITDA Per Share Growth Rate was 92.50% per year. During the past 5 years, the average EBITDA Per Share Growth Rate was 75.40% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.

During the past 13 years, the highest 3-Year average EBITDA Per Share Growth Rate of Bio Green Med Solution was 92.50% per year. The lowest was 15.70% per year. And the median was 63.50% per year.


Bio Green Med Solution  (NAS:BGMS) 3-Year EBITDA Growth Rate Explanation

EBITDA per Share is the amount of Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) per outstanding share of the company's stock.

Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) is what the company earns before it expenses interest, taxes, depreciation and amortization.


Bio Green Med Solution 3-Year EBITDA Growth Rate Related Terms


BGMS vs SILO, ALZN, ENVB: 3-Year EBITDA Growth Rate Comparison

For the Building Products & Equipment subindustry, Bio Green Med Solution's 3-Year EBITDA Growth Rate, along with its competitors' market caps and 3-Year EBITDA Growth Rate data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Bio Green Med Solution 3-Year EBITDA Growth Rate vs Construction Industry

For the Construction industry and Industrials sector, Bio Green Med Solution's 3-Year EBITDA Growth Rate distribution charts can be found below:

* The bar in red indicates where Bio Green Med Solution's 3-Year EBITDA Growth Rate falls into.


BGMS
46GF Score
Bio Green Med Solution Inc BGMS
3-Year EBITDA Growth Rate is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Bio Green Med Solution 3-Year EBITDA Growth Rate Calculation

This is the 3-year average growth rate of EBITDA per Share. The growth rate is calculated using exponential compounding based on the latest four year annual data.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.

What does a 3-Year EBITDA Growth Rate of 92.50% mean?
Bio Green Med Solution (BGMS) has a 3-Year EBITDA Growth Rate of 92.50% as of Jun. 2026. 3-Year EBITDA Growth Rate is the 3-year average growth rate of EBITDA per share. View historical data for Bio Green Med Solution and its competitors. This is 46% above median its historical median of 63.50. Over the past decade, Bio Green Med Solution's 3-Year EBITDA Growth Rate has ranged from 15.70 to 92.50. According to the industry distribution chart, Bio Green Med Solution ranks #68 out of 1450 companies in the Construction industry, placing it in the top 4.7%.
Is Bio Green Med Solution's 3-Year EBITDA Growth Rate too high?
Bio Green Med Solution's current 3-Year EBITDA Growth Rate of 92.50% is 46% above median its 10-year median of 63.50. Over the past 10 years, this metric has ranged from a low of 15.70 to a high of 92.50. The Construction industry median 3-Year EBITDA Growth Rate is 8.80. Bio Green Med Solution's value of 92.50% is 951.1% above this industry median. Based on the distribution chart, Bio Green Med Solution ranks #68 out of 1450 companies in the Construction industry, which is in the top quartile — a strong position relative to peers. Overall, Bio Green Med Solution has a GF Score™ of 46/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Bio Green Med Solution's 3-Year EBITDA Growth Rate compare to SILO and ALZN?
According to the Construction industry distribution chart, Bio Green Med Solution ranks #68 out of 1450 companies for 3-Year EBITDA Growth Rate. This places Bio Green Med Solution in the top 5% of its industry — outperforming the majority of peers. The industry median 3-Year EBITDA Growth Rate is 8.80. Bio Green Med Solution's value of 92.50% is 951.1% above this benchmark. Historically, Bio Green Med Solution's own 3-Year EBITDA Growth Rate has ranged from 15.70 to 92.50 over the past decade. While the company's 10-year median is 63.50 vs. the industry median of 8.80, Bio Green Med Solution has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 3-Year EBITDA Growth Rate for a Construction company?
The median 3-Year EBITDA Growth Rate among Construction companies is 8.80, based on 1,450 companies in the industry. Companies in the top quartile (top 25%) have a 3-Year EBITDA Growth Rate significantly above this median, while those in the bottom quartile fall well below. However, 3-Year EBITDA Growth Rate should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Bio Green Med Solution's current 3-Year EBITDA Growth Rate of 92.50% is 951.1% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 3-Year EBITDA Growth Rate mean?
A high 3-Year EBITDA Growth Rate can signal that a stock is expensive relative to its fundamentals. 3-Year EBITDA Growth Rate is the 3-year average growth rate of EBITDA per share. View historical data for Bio Green Med Solution and its competitors. For the Construction industry, the median 3-Year EBITDA Growth Rate is 8.80 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Bio Green Med Solution's current 3-Year EBITDA Growth Rate is 92.50%, which is 46% above median its own 10-year median of 63.50. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Bio Green Med Solution stock overvalued right now?
Based on GuruFocus' analysis, Bio Green Med Solution (BGMS) is currently considered Possible Value Trap. The stock's GF Value™ is $2.61, compared to a current price of $0.88 — trading 66.4% below its estimated fair value. The current 3-Year EBITDA Growth Rate is 92.50%, which is 46% above median its 10-year median of 63.50 and 951.1% above the Construction industry median of 8.80. Bio Green Med Solution's overall GF Score™ is 46/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 3-Year EBITDA Growth Rate calculated?
3-Year EBITDA Growth Rate is calculated from a company's financial statements. For Bio Green Med Solution (BGMS), the current 3-Year EBITDA Growth Rate is 92.50% as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Bio Green Med Solution (BGMS) Overvalued in 2026?

Based on GuruFocus' analysis, Bio Green Med Solution stock appears to be undervalued. The current stock price of $0.88 is trading 66.4% below its estimated GF Value™ of $2.61. GuruFocus considers Bio Green Med Solution to be Possible Value Trap.

Key valuation signals for BGMS:

  • 3-Year EBITDA Growth Rate: 92.50% (46% above median its 10-year median of 63.50)
  • GF Value™: $2.61 vs. price of $0.88 (66.4% below fair value)
  • GF Score™: 46/100 with 3 warning signs
  • Industry Position: 951.1% above the Construction median (#68 of 1450)

No single metric tells the full story. See the BGMS stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Bio Green Med Solution Business Description

Other Exchanges BGMSP.PFD:USA
Address No. 8 Jalan Kerinchi, Avenue 5, Level 10, Tower 11, Kuala Lumpur, SGR, MYS, 59200
Bio Green Med Solution Inc is engaged in the supply and trading of protective and fire safety equipment. The company distributes products such as fire extinguishers, foam systems, fire-resistant doors, personal protective equipment, and safety apparel. It also provides fire safety systems, including sprinkler systems, fire alarm systems, valves, and CO2 systems. The company operates across commercial, industrial, healthcare, and residential sectors, with a focus on distribution and compliance with applicable safety standards.
46GF Score

Get the complete analysis for BGMS

3-Year EBITDA Growth Rate is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$0.88
Price
$2.61
GF Value